Generics industry complains of EFPIA 'misinformation' on counterfeiting
This article was originally published in Scrip
Executive Summary
In a 10 July letter to the European Commission, the European Generic medicines Association (EGA) has drawn attention to what it calls 'misinformation' emanating from the R&D-based industry association, the European Federation of Pharmaceutical Industries and Associations (EFPIA), on counterfeiting in the generics sector.